Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. (Q54114743)
Jump to navigation
Jump to search
scientific article published in December 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. |
scientific article published in December 1998 |
Statements
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia (English)
Knechtli CJ
Goulden NJ
Hancock JP
Grandage VL
Harris EL
Garland RJ
Jones CG
Rowbottom AW
Hunt LP
Green AF
Clarke E
Lankester AW
Cornish JM
Pamphilon DH
1 December 1998